Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Interleukin-4 activates androgen receptor through CBP/p300.

Lee SO, Chun JY, Nadiminty N, Lou W, Feng S, Gao AC.

Prostate. 2009 Feb 1;69(2):126-32. doi: 10.1002/pros.20865.

2.

Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.

Gong J, Zhu J, Goodman OB Jr, Pestell RG, Schlegel PN, Nanus DM, Shen R.

Oncogene. 2006 Mar 30;25(14):2011-21.

PMID:
16434977
3.

Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines.

Santer FR, Höschele PP, Oh SJ, Erb HH, Bouchal J, Cavarretta IT, Parson W, Meyers DJ, Cole PA, Culig Z.

Mol Cancer Ther. 2011 Sep;10(9):1644-55. doi: 10.1158/1535-7163.MCT-11-0182.

4.

p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.

Debes JD, Schmidt LJ, Huang H, Tindall DJ.

Cancer Res. 2002 Oct 15;62(20):5632-6.

5.

Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.

Lee SO, Lou W, Hou M, Onate SA, Gao AC.

Oncogene. 2003 Sep 11;22(39):7981-8.

PMID:
12970746
6.

Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.

Narayanan BA, Narayanan NK, Re GG, Nixon DW.

Int J Cancer. 2003 Mar 20;104(2):204-12. Erratum in: Int J Cancer. 2016 Aug 15;139(4):E8.

7.

TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.

Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S.

Cancer Res. 2008 May 1;68(9):3486-94. doi: 10.1158/0008-5472.CAN-07-6059.

8.
9.

Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.

Lee SO, Lou W, Nadiminty N, Lin X, Gao AC.

Prostate. 2005 Jul 1;64(2):160-7.

PMID:
15678501
10.

p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.

Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H.

Cancer Res. 2014 Mar 15;74(6):1870-80. doi: 10.1158/0008-5472.CAN-13-2485.

11.

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

Nadiminty N, Lou W, Sun M, Chen J, Yue J, Kung HJ, Evans CP, Zhou Q, Gao AC.

Cancer Res. 2010 Apr 15;70(8):3309-19. doi: 10.1158/0008-5472.CAN-09-3703.

12.

Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells.

Ianculescu I, Wu DY, Siegmund KD, Stallcup MR.

J Biol Chem. 2012 Feb 3;287(6):4000-13. doi: 10.1074/jbc.M111.300194. Erratum in: J Biol Chem. 2012 Oct 19;287(43):35985.

13.
14.

Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.

Heemers HV, Schmidt LJ, Kidd E, Raclaw KA, Regan KM, Tindall DJ.

Prostate. 2010 Jun 15;70(9):959-70. doi: 10.1002/pros.21130.

15.

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.

Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345.

16.

Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.

Choi KC, Park S, Lim BJ, Seong AR, Lee YH, Shiota M, Yokomizo A, Naito S, Na Y, Yoon HG.

Biochem J. 2011 Jan 1;433(1):235-44. doi: 10.1042/BJ20100980. Erratum in: Biochem J. 2011 Jan 14;433(3):535. Sung, Ah-Reum [corrected to Seong, Ah-Reum].

PMID:
20955177
18.
20.

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z.

Cancer Res. 1998 Oct 15;58(20):4640-5.

Items per page

Supplemental Content

Support Center